Rohto Pharmaceutical Co(RPHCF)
$15.99-0.49 (-3.00%)
RPHCF
Rohto Pharmaceutical Co earnings date
$15.99
At close:-0.49 (-3.00%)
Rohto Pharmaceutical Co (RPHCF) Q2 2026 Earnings Report
3 Followers
RPHCF Q2 2026 EPS Results
- Actual EPS
- $0.16
- Consensus EPS
- $0.20
- Beat/Miss
- Missed by -$0.04
- One Year Ago EPS
- $0.16
RPHCF Q2 2026 Revenue Results
- Actual Revenue
- $546.53M
- Expected Revenue
- $558.57M
- Beat/Miss
- Missed by -$12.04M
- YoY Revenue Growth
- +6.18%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/12/2026
- Time
- Before Open
- Conference Call
- Thursday, November 12, 2026
RPHCF Upcoming Earnings
Rohto Pharmaceutical Co's next earnings date is estimated for February 12, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
RPHCF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 12, 2027 | 2026 (Q3) | 0.33- | 0.29 | ― | ― |
| Nov 12, 2026 | 2026 (Q2) | 0.200.16 | 0.16 | -0.35% (-0.00) | |
| Aug 06, 2026 | 2026 (Q1) | 0.250.29 | 0.33 | -9.50% (-0.03) | |
| May 13, 2026 | 2025 (Q4) | 0.190.17 | 0.17 | -3.54% (-0.01) | |
| Feb 12, 2026 | 2025 (Q3) | 0.280.29 | 0.33 | -9.71% (-0.03) | |
| Nov 13, 2025 | 2025 (Q2) | 0.160.16 | 0.12 | 33.76% (+0.04) | |
| Aug 06, 2025 | 2025 (Q1) | ―0.33 | 0.23 | 40.10% (+0.09) | |
| May 13, 2025 | 2024 (Q4) | 0.160.17 | 0.13 | 30.69% (+0.04) | |
| Feb 12, 2025 | 2024 (Q3) | 0.310.33 | 0.26 | 24.26% (+0.06) | |
| Nov 13, 2024 | 2024 (Q2) | 0.220.12 | 0.21 | -40.83% (-0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
